Ad
related to: rifampicin wikipediaWorking to be "the most powerful patient advocate in America" - Forbes
- Research You Can Rely On
Our team works hard to provide you
with the latest healthcare info.
- GoodRx® & Medicare
Beat your Medicare Copay!
Discover More Savings Options Today
- Transparent Pricing
Healthcare is confusing. We make it
simple. Use GoodRx to start saving.
- Healthcare Professionals
GoodRx® Can Help You Get Major
Savings For Your Patients
- Research You Can Rely On
Search results
Results from the WOW.Com Content Network
Rifampicin, also known as rifampin, is an ansamycin antibiotic used to treat several types of bacterial infections, including tuberculosis (TB), ...
Lepetit introduced Rifampicin, an orally active rifamycin, in 1966. [16] Rifabutin, a derivative of rifamycin S, was invented by Italian drug manufacturer Achifar in 1975 and came onto the US market in 1992. [16] Hoechst Marion Roussel (now part of Aventis) introduced rifapentine to the US market in 1998, with Achifar having synthesized it in ...
It is a fixed dose combination of rifampicin, isoniazid, and pyrazinamide. [1] It is used either by itself or along with other antituberculosis medication . [ 1 ] It is taken by mouth .
This page was last edited on 5 November 2023, at 03:42 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Management of tuberculosis refers to techniques and procedures utilized for treating tuberculosis (TB), or simply a treatment plan for TB.. The medical standard for active TB is a short course treatment involving a combination of isoniazid, rifampicin (also known as Rifampin), pyrazinamide, and ethambutol for the first two months.
Isoniazid/rifampicin, also known as isoniazid/rifampin, is a medication used to treat tuberculosis. [1] It is a fixed dose combination of isoniazid and rifampicin (rifampin). [1] It is used together with other antituberculosis medication. [1] It is taken by mouth. [1] It is on the World Health Organization's List of Essential Medicines. [2]
Multidrug-resistant tuberculosis (MDR-TB) is a form of tuberculosis (TB) infection caused by bacteria that are resistant to treatment with at least two of the most powerful first-line anti-TB medications (drugs): isoniazid and rifampicin.
Dapsone is commonly used in combination with rifampicin and clofazimine for the treatment of leprosy. [4] It is also used to both treat and prevent pneumocystis pneumonia (PCP). [4] [10] It is also used for toxoplasmosis in people unable to tolerate trimethoprim with sulfamethoxazole. [10]